APA (7th ed.) Citation

Laganà, M., Rodella, S., Bettini, D. L., Esposito, A., Abate, A., Ambrosini, R., . . . Calza, S. (2026). Chemo–immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma. European Journal of Endocrinology, 194(2), 199. https://doi.org/10.1093/ejendo/lvag008

Chicago Style (17th ed.) Citation

Laganà, Marta, et al. "Chemo–immunotherapy with Cisplatin and Nivolumab as Second-line Approach in Metastatic Adrenocortical Carcinoma." European Journal of Endocrinology 194, no. 2 (2026): 199. https://doi.org/10.1093/ejendo/lvag008.

MLA (9th ed.) Citation

Laganà, Marta, et al. "Chemo–immunotherapy with Cisplatin and Nivolumab as Second-line Approach in Metastatic Adrenocortical Carcinoma." European Journal of Endocrinology, vol. 194, no. 2, 2026, p. 199, https://doi.org/10.1093/ejendo/lvag008.